Marimed (MRMD) Operating Income (2011 - 2026)
Marimed (MRMD) posted quarterly Operating Income of $125000.0 for Q1 2026, up 113.74% year-over-year from $58483.3 in Q1 2025, and up 102.76% quarter-over-quarter from -$4.5 million in Q4 2025.
Marimed (MRMD) Operating Income (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Operating Income for 16 consecutive years, with $125000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income rose 113.74% year-over-year to $125000.0; the TTM figure through Mar 2026 stood at -$1.7 million (down 2055.84% YoY), while the FY2025 annual figure was -$2.8 million, down 208.09% from the prior year.
- Operating Income advanced to $125000.0 in Q1 2026 per MRMD's latest filing, from -$4.5 million in the prior quarter.
- Across five years, Operating Income topped out at $7.0 million in Q1 2022 and bottomed at -$4.5 million in Q4 2025.
- Historically, Operating Income has averaged $2.1 million across 5 years, with a median of $2.0 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Income surged 156.77% — and 2025, when it slumped 208.24%.
- Marimed's Operating Income stood at $3.1 million in 2022, then fell by 21.95% to $2.4 million in 2023, then tumbled by 160.89% to -$1.5 million in 2024, then plunged by 208.24% to -$4.5 million in 2025, then surged by 102.76% to $125000.0 in 2026.
- Business Quant data shows MRMD's Operating Income at $125000.0 in Q1 2026, -$4.5 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Marimed | 28.08 Mn | 17.74 Mn | 16.23 Mn | 418,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 418,000.00 |
| Mar 31, 2026 | 125,000.00 |
| Dec 31, 2025 | -4.53 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | -910,000.00 |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 956,000.00 |
| Mar 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | 2.41 Mn |
| Sep 30, 2023 | 3.29 Mn |
| Jun 30, 2023 | 3.55 Mn |
| Mar 31, 2023 | 5.14 Mn |
| Dec 31, 2022 | 3.09 Mn |
| Sep 30, 2022 | 5.74 Mn |
| Jun 30, 2022 | 4.50 Mn |
| Mar 31, 2022 | 7.05 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 6.62 Mn |